Canada markets closed

Stryker Corporation (SYK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
243.11+2.34 (+0.97%)
At close: 04:04PM EST
236.33 -6.78 (-2.79%)
After hours: 06:07PM EST

Stryker Corporation

2825 Airview Boulevard
Kalamazoo, MI 49002
United States
269 385 2600
https://www.stryker.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees46,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Kevin A. LoboChairman, CEO & Pres3.59M22.31M1965
Mr. Glenn S. BoehnleinVP & CFO1.46MN/A1962
Mr. Timothy John ScannellExec. Advisor1.74M22.55M1965
Mr. Viju S. MenonGroup Pres of Global Quality & Operations1.08MN/A1968
Mr. J. Andrew PierceGroup Pres of MedSurg & Neurotechnology1.41M1.43M1974
Mr. Spencer S. StilesGroup Pres of Orthopaedics & Spine1.33M2.24M1977
Mr. William E. Berry Jr.VP & Chief Accounting OfficerN/AN/A1966
Mr. Robert C. CohenCTO and VP of Global R&D - Joint ReplacementN/AN/AN/A
Mr. Alan DouvilleVP, Chief Information Officer & Chief Information Security OfficerN/AN/AN/A
Mr. Jason BeachVP of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Corporate Governance

Stryker Corporation’s ISS Governance QualityScore as of November 28, 2022 is 4. The pillar scores are Audit: 6; Board: 4; Shareholder Rights: 4; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.